# Periodic Use of Continuous Glucose Monitoring With Personalized Diet Interventions Using AI Camera Among Non-insulin Treated Type 2 Diabetes

Study · id `cardio:ct-nct06594055` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06594055](<https://clinicaltrials.gov/study/NCT06594055>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06594055

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT06594055. Randomized; no masking; primary purpose treatment. Start 2023-04-04 (actual); primary completion 2024-10-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT06594055, source copy `cardio:ctgov-nct06594055-2025-03-07`, retrieved 2026-10-26)
- Started: 2023-04-04 (actual) (ClinicalTrials.gov record NCT06594055, source copy `cardio:ctgov-nct06594055-2025-03-07`, retrieved 2026-10-26)
- Primary completion: 2024-10-31 (actual) (ClinicalTrials.gov record NCT06594055, source copy `cardio:ctgov-nct06594055-2025-03-07`, retrieved 2026-10-26)
- Completion: 2024-10-31 (actual) (ClinicalTrials.gov record NCT06594055, source copy `cardio:ctgov-nct06594055-2025-03-07`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT06594055, source copy `cardio:ctgov-nct06594055-2025-03-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06594055-2025-03-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Periodic Use of Continuous Glucose Monitoring With Personalized Diet Interventions Using AI Camera Among Non-insulin Treated Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): Continuous Glucose Monitoring
- Intervention (Device): Self-monitoring blood glucose
- Intervention (Device): AI food camera
- Intervention (Device): Food diary
- Lead sponsor: Kangbuk Samsung Hospital
- Lead sponsor class: OTHER
- Collaborator: Daewoong Pharmaceutical Co. LTD.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Kangbuk Samsung Hospital (`cardio:org-kangbuk-samsung-hospital`)
- Registry lists this organization as a collaborator: Daewoong Pharmaceutical Co. LTD. (`cardio:org-daewoong-pharmaceutical-co-ltd`)

## Provenance

Content hash: e51c53e07d2cca9d3f73ce923e59d18aeb478be6ddf490cd2f2b177e8f45d8bb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
